| WKN: | A0MUUJ |
| ISIN: | US68375N1037 |
| Land: | USA |
| Branche: | Chemie, Pharma, Bio- & Medizintechnik |
| Sektor: | Pharma |
Weshalb die Opko Health-Aktie
ein D-Rating hat,
erfahren Sie im Performance-Check
vom 09. März 2026 Info.
| Rang | Datum | Vorjahr | Schluss | Performance |
|---|---|---|---|---|
| 1 | 2020 | 1,31 | 3,35 | 155,73% |
| 2 | 2010 | 1,12 | 2,70 | 141,07% |
| 3 | 2013 | 3,51 | 6,32 | 80,06% |
| 4 | 2011 | 2,70 | 3,65 | 35,19% |
| 5 | 2021 | 3,35 | 4,34 | 29,55% |
| 6 | 2014 | 6,32 | 7,88 | 24,68% |
| 7 | 2023 | 1,12 | 1,39 | 24,11% |
| 8 | 2015 | 7,88 | 9,44 | 19,80% |
| 9 | 2009 | 0,96 | 1,12 | 16,67% |
| 10 | 2016 | 9,44 | 10,83 | 14,72% |
| 11 | 2024 | 1,39 | 1,39 | 0,00% |
| 12 | 2012 | 3,65 | 3,51 | -3,84% |
| 13 | 2026 | 1,09 | 0,96 | -11,93% |
| 14 | 2025 | 1,39 | 1,09 | -21,58% |
| 15 | 2018 | 4,06 | 2,52 | -37,93% |
| 16 | 2019 | 2,52 | 1,31 | -48,02% |
| 17 | 2008 | 1,94 | 0,96 | -50,52% |
| 18 | 2017 | 10,83 | 4,06 | -62,51% |
| 19 | 2022 | 4,34 | 1,12 | -74,19% |
| Rang | Datum | Vorjahr | Schluss | Performance |
|---|---|---|---|---|
| 1 | 2022 | 4,34 | 1,12 | -74,19% |
| 2 | 2017 | 10,83 | 4,06 | -62,51% |
| 3 | 2008 | 1,94 | 0,96 | -50,52% |
| 4 | 2019 | 2,52 | 1,31 | -48,02% |
| 5 | 2018 | 4,06 | 2,52 | -37,93% |
| 6 | 2025 | 1,39 | 1,09 | -21,58% |
| 7 | 2026 | 1,09 | 0,96 | -11,93% |
| 8 | 2012 | 3,65 | 3,51 | -3,84% |
| 9 | 2024 | 1,39 | 1,39 | 0,00% |
| 10 | 2016 | 9,44 | 10,83 | 14,72% |
| 11 | 2009 | 0,96 | 1,12 | 16,67% |
| 12 | 2015 | 7,88 | 9,44 | 19,80% |
| 13 | 2023 | 1,12 | 1,39 | 24,11% |
| 14 | 2014 | 6,32 | 7,88 | 24,68% |
| 15 | 2021 | 3,35 | 4,34 | 29,55% |
| 16 | 2011 | 2,70 | 3,65 | 35,19% |
| 17 | 2013 | 3,51 | 6,32 | 80,06% |
| 18 | 2010 | 1,12 | 2,70 | 141,07% |
| 19 | 2020 | 1,31 | 3,35 | 155,73% |